Insulin Delivery Using the DBLG1 Closed-loop on Glycemic Control and PROMs in Adults Living With Type 1 Diabetes - Trial NCT06154135
Access comprehensive clinical trial information for NCT06154135 through Pure Global AI's free database. This phase not specified trial is sponsored by Erasme University Hospital and is currently Enrolling by invitation. The study focuses on Diabetes Mellitus, Type 1. Target enrollment is 165 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Erasme University Hospital
Timeline & Enrollment
N/A
Dec 30, 2022
Jul 30, 2026
Primary Outcome
Time in range
Summary
To evaluate the impact of the DBLG1 hybrid closed-loop system on glycemic control and
 patient-reported outcomes in adults living with type 1 diabetes under real-life conditions.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06154135
Non-Device Trial